Englitazone

From WikiMD's Wellnesspedia

Englitazone is a thiazolidinedione derivative, which is a type of antidiabetic drug. It was developed by Eli Lilly and Company but was never marketed.

Mechanism of Action[edit | edit source]

Englitazone works by activating peroxisome proliferator-activated receptors (PPARs), specifically PPARγ. PPARs are a group of nuclear receptor proteins that function as transcription factors regulating the expression of genes. PPARγ activation results in an increase in the transcription of insulin-responsive genes, leading to better cellular response to insulin.

Pharmacokinetics[edit | edit source]

The pharmacokinetics of englitazone, like other thiazolidinediones, involves absorption in the gastrointestinal tract after oral administration. It is extensively metabolized in the liver and excreted in the urine and feces.

Side Effects[edit | edit source]

Potential side effects of englitazone include weight gain, edema, and potential increase in cardiovascular disease risk. It may also cause or exacerbate congestive heart failure in some patients.

Development and Marketing[edit | edit source]

Englitazone was developed by Eli Lilly and Company but was never marketed. The reasons for this are not publicly disclosed, but may be related to the side effect profile or market competition.

See Also[edit | edit source]


Englitazone Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD